Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Animal Antibiotics and Antimicrobials Market

Animal Antibiotics and Antimicrobials Market Trends

Report ID: GMI5608
Published Date: May 2023
Report Format: PDF

Download Free Sample

Animal Antibiotics and Antimicrobials Market Trends

There has been rising concerns regarding the health of animals. The rising animal healthcare spending and the growing demand for pet insurance will lead to high demand for animal pharmaceuticals including antibiotics and antimicrobials, which is the most significant factor driving the revenue for this market. Increasing initiatives concerning animal health and welfare along with increasing incidence of zoonotic diseases are also expected to accelerate the overall progression of the market.

Furthermore, the surging demand for dairy products, and subsequent rise in livestock population facilitated by organized farming which will further expand the animal antibiotics antimicrobials market's growth rate in the future.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for animal antibiotics & antimicrobials was valued at over USD 4.6 billion in 2022 and is forecasted to reach over USD 6.7 billion by 2032.

The tetracyclines segment accounted for over 42.6% share of the animal antibiotics and antimicrobials market in 2022 and is expected to record robust demand due to its highest potency against pathogenic microorganisms.

The livestock animals segment held a 57.9% market share in 2022 and is projected to expand further driven by rising demand for animal-based products & the introduction of regulations to prevent diseases.

Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Virbac, Vetoquinol, Bayer AG, Novartis AG, Eli Lilly, and Sanofi are some of the leading players in the animal antibiotics and antimicrobials market.